Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Saccharomyces cerevisiae Transcriptional regulatory protein EDS1 (EDS1), partial CSB-YP463122SVP
CSB-EP463122SVP
CSB-BP463122SVP
CSB-MP463122SVP
CSB-EP463122SVP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Topoisomerase I damage affected protein 7 (TDA7), partial CSB-YP463123SVP1
CSB-EP463123SVP1
CSB-BP463123SVP1
CSB-MP463123SVP1
CSB-EP463123SVP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Adenylosuccinate synthetase (ADE12) CSB-YP463124SVP
CSB-EP463124SVP
CSB-BP463124SVP
CSB-MP463124SVP
CSB-EP463124SVP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Altered inheritance of mitochondria protein 23, mitochondrial (AIM23) CSB-YP463125SVP
CSB-EP463125SVP
CSB-BP463125SVP
CSB-MP463125SVP
CSB-EP463125SVP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae COX assembly mitochondrial protein (CMC1) CSB-YP463126SVP
CSB-EP463126SVP
CSB-BP463126SVP
CSB-MP463126SVP
CSB-EP463126SVP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Oleate activated transcription factor 3 (OAF3), partial CSB-YP463127SVP
CSB-EP463127SVP
CSB-BP463127SVP
CSB-MP463127SVP
CSB-EP463127SVP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Regulatory protein SIR1 (SIR1), partial CSB-YP463128SVP
CSB-EP463128SVP
CSB-BP463128SVP
CSB-MP463128SVP
CSB-EP463128SVP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae 6-phosphogluconolactonase 3 (SOL3) CSB-YP463129SVP
CSB-EP463129SVP
CSB-BP463129SVP
CSB-MP463129SVP
CSB-EP463129SVP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Elongation factor G, mitochondrial (MEF1), partial CSB-YP463130SVP
CSB-EP463130SVP
CSB-BP463130SVP
CSB-MP463130SVP
CSB-EP463130SVP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae L-serine dehydratase (SDL1) CSB-YP463131SVP
CSB-EP463131SVP
CSB-BP463131SVP
CSB-MP463131SVP
CSB-EP463131SVP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Mitochondrial distribution and morphology protein 10 (MDM10) CSB-YP463132SVP
CSB-EP463132SVP
CSB-BP463132SVP
CSB-MP463132SVP
CSB-EP463132SVP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila ananassae cGMP-specific 3',5'-cyclic phosphodiesterase (Pde6), partial CSB-YP463133DKY
CSB-EP463133DKY
CSB-BP463133DKY
CSB-MP463133DKY
CSB-EP463133DKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila ananassae Eukaryotic translation initiation factor 3 subunit D-1 (eIF-3p66), partial CSB-YP463134DKY
CSB-EP463134DKY
CSB-BP463134DKY
CSB-MP463134DKY
CSB-EP463134DKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila ananassae Ribosome-releasing factor 2, mitochondrial (EF-G2), partial CSB-YP463135DKY
CSB-EP463135DKY
CSB-BP463135DKY
CSB-MP463135DKY
CSB-EP463135DKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila ananassae Eukaryotic translation initiation factor 3 subunit F-1 (eIF3-S5-1) CSB-YP463136DKY
CSB-EP463136DKY
CSB-BP463136DKY
CSB-MP463136DKY
CSB-EP463136DKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila ananassae CDGSH iron-sulfur domain-containing protein 2 homolog (GF16608), partial CSB-YP463137DKY
CSB-EP463137DKY
CSB-BP463137DKY
CSB-MP463137DKY
CSB-EP463137DKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila ananassae Facilitated trehalose transporter Tret1 (Tret1), partial CSB-YP463138DKY
CSB-EP463138DKY
CSB-BP463138DKY
CSB-MP463138DKY
CSB-EP463138DKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila ananassae Succinate dehydrogenase assembly factor 2-A, mitochondrial (GF11110) CSB-YP463139DKY
CSB-EP463139DKY
CSB-BP463139DKY
CSB-MP463139DKY
CSB-EP463139DKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila ananassae Ribosome biogenesis protein WDR12 homolog (GF14067) CSB-YP463140DKY
CSB-EP463140DKY
CSB-BP463140DKY
CSB-MP463140DKY
CSB-EP463140DKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila ananassae Anamorsin homolog (l (2)35Bg) CSB-YP463141DKY
CSB-EP463141DKY
CSB-BP463141DKY
CSB-MP463141DKY
CSB-EP463141DKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>